Victory Square Portfolio Company Hydreight Adds Semaglutide to Product Offerings

December 20, 2023

VANCOUVER, British Columbia, Dec. 20, 2023 (GLOBE NEWSWIRE) — Victory Square Technologies Inc. (“Victory Square”) (CSE:VST) (OTC:VSQTF) (FWB:6F6) is pleased to announce that portfolio company Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV: NURS)(OTCQB:HYDTF)(FSE: SO6), a mobile clinical network and medical platform which enables flexible, at-home medical services across 50 states in the United States, is excited to announce that healthcare providers and their patients now have access to Semaglutide through the Hydreight platform. 

Read more at globenewswire.com

Related news for (VSQTF)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.